BlackRock’s Bolt Biotherapeutics BOLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60.9K | Sell |
10,550
-2,882
| -21% | -$16.6K | ﹤0.01% | 4882 |
|
|
2025
Q1 | $107K | Sell |
13,432
-73
| -0.5% | -$584 | ﹤0.01% | 4705 |
|
|
2024
Q4 | $145K | Buy |
13,505
+25
| +0.2% | +$268 | ﹤0.01% | 4631 |
|
|
2024
Q3 | $175K | Buy |
13,480
+127
| +1% | +$1.65K | ﹤0.01% | 4507 |
|
|
2024
Q2 | $200K | Buy |
13,353
+605
| +5% | +$9.08K | ﹤0.01% | 4497 |
|
|
2024
Q1 | $357K | Sell |
12,748
-116
| -0.9% | -$3.25K | ﹤0.01% | 4403 |
|
|
2023
Q4 | $288K | Sell |
12,864
-37
| -0.3% | -$829 | ﹤0.01% | 4475 |
|
|
2023
Q3 | $268K | Sell |
12,901
-1,494
| -10% | -$31.1K | ﹤0.01% | 4529 |
|
|
2023
Q2 | $369K | Buy |
14,395
+673
| +5% | +$17.2K | ﹤0.01% | 4489 |
|
|
2023
Q1 | $381K | Buy |
13,722
+66
| +0.5% | +$1.84K | ﹤0.01% | 4519 |
|
|
2022
Q4 | $355K | Sell |
13,656
-8,504
| -38% | -$221K | ﹤0.01% | 4615 |
|
|
2022
Q3 | $657K | Sell |
22,160
-357
| -2% | -$10.6K | ﹤0.01% | 4546 |
|
|
2022
Q2 | $918K | Sell |
22,517
-58,102
| -72% | -$2.37M | ﹤0.01% | 4476 |
|
|
2022
Q1 | $4.42M | Sell |
80,619
-1,816
| -2% | -$99.5K | ﹤0.01% | 3954 |
|
|
2021
Q4 | $8.08M | Buy |
82,435
+9,709
| +13% | +$952K | ﹤0.01% | 3723 |
|
|
2021
Q3 | $18.4M | Buy |
72,726
+25,633
| +54% | +$6.49M | ﹤0.01% | 3282 |
|
|
2021
Q2 | $14.6M | Buy |
47,093
+5,134
| +12% | +$1.59M | ﹤0.01% | 3422 |
|
|
2021
Q1 | $27.6M | Buy |
+41,959
| New | +$27.6M | ﹤0.01% | 2954 |
|